throbber
United States Patent r19J
`Balazs et al.
`
`[54] CROSS-LINKED GELS OF HYALURONIC
`ACID AND PRODUCTS CONTAINING SUCH
`GELS
`
`[75]
`
`Inventors: Endre A. Balazs, Riverdale, N.Y.;
`Adolf Leshchiner, Fairview, N.J.
`
`[73] Assignee: Biomatrix, Inc., Ridgefield, N.J.
`
`[21] Appl. No.: 755,976
`
`[22] Filed:
`
`Jul. 18, 1985
`
`Related U.S. Application Data
`[62] Division of Ser. No. 678,895, Dec. 6, 1984, abandoned.
`
`[51]
`Int. CI.4 .............................................. C08B 37/08
`[52] U.S. CI . ........................................ 524/27; 524/29;
`536/4.1
`[58] Field of Search ............................ 536/4.1; 524/27
`
`[I I] Patent Number:
`[45] Date of Patent:
`
`4,605,691
`Aug. 12, 1986
`
`[56]
`
`References Cited
`U.S. PATENT DOCUMENTS
`3,357,784 12/1967 Kasper .................................... 8/129
`4,141,973 2/1979 Balazs ................................. 536/55.1
`4,303,676 12/1981 Balazs .................................. 424/359
`4,487,865 12/1984 Balazs et al. .......................... 524/29
`4,500,676 2/1985 Balazs et al. .......................... 424/81
`Primary Examiner-Ronald W. Griffin
`Attorney, Agent, or Firm-Sheldon Palmer
`[57]
`ABSTRACT
`Disclosed are cross-linked gels ofhyaluronic acid, alone
`or mixed with other hydrophilic polymers and contain(cid:173)
`ing various substances or covalently bonded low molec(cid:173)
`ular weight substances and processes for preparing
`them. These products are useful in numerous applica(cid:173)
`tions including cosmetic formulations and as drug deliv(cid:173)
`ery systems.
`
`6 Claims, 2 Drawing Figures
`
`2/)()()
`
`/DI)()
`
`~(cid:173)~
`~
`~
`'i L_ ____ ,.._:::::==::===:::=~---
`
`.5
`EXAMPL.£ .3. SWEl.LJNG li'-ATI() (),t:' Gi'a,S"S-UNita> JIA GEI.S Ar
`/)J,t:'~Nr CONC',EN'Tie-4770/VS OF KA IN ,sT,,tA'TIN(; SOt.UTIONS
`(/,IA/tws WEIG/IT .t'Al70 ABoVT 1.-1, R,:uur TE"MP.QATV,('£, / M:>V.R).
`
`Exhibit 1062
`Prollenium v. Allergan
`
`

`

`U.S. Patent Aug. 12, 1986
`
`Sheet 1 of2
`
`4,605,691
`
`FIG.I
`
`4000
`
`JO(JO
`
`2000
`
`/0{)0
`
`•
`
`•
`
`s
`10 /IA CtJNCENT.:eAT/tJ/11, WT.~
`- £XAAfPL£ 3. SWELLING RATIO OF C/i'tJSS-LINl<ED /.IA GELS AT
`01,CrERENT CONCeNTR.4770NS OF f/A IN STARTING SOLLJTIONS
`(/.IA/DVS WE/6/ITR,4T/tJ //BOUT /:0 ROOM T£MPERATVRE, / I/OUR).
`
`

`

`U.S. Patent· Aug.12, 1986
`
`Sheet 2 of2
`
`4,605,691
`
`F!G.2
`
`4000
`
`3000
`
`2000
`
`/000
`
`•
`
`•
`
`/.0
`
`/.IA/011S tllO/JIR R4TIO
`£X4A,f PL£ 4. SWEL.LING RATIO OF CROSS-LINKED 1./A GELS AT .D/,t:'FERENT
`/.IA/OVS MOL.AR RATIOS
`{ t/A CONCEN'TJ?ATION IN STARTING
`SOLl/TIONS 4 WT. % 1 ROOM TEMPERATURe1
`I-IOVR).
`f
`
`ZO
`
`

`

`1
`
`4,605,691
`
`CROSS-LINKED GELS OF HYALURONIC ACID
`AND PRODUCTS CONTAINING SUCH GELS
`
`This application is a division of application Ser. No. 5
`678,895, filed Dec. 6, 1984, now abandoned.
`BACKGROUND OF THE INVENTION
`1. Field of the Invention
`The present invention relates to gels and mixed gels
`of hyaluronic acid (HA), formulations containing them
`and methods for preparing them.
`2. The Prior Art
`Hyaluronic acid is a well known, naturally occurring
`polysaccharide containing alternating N-acetyl-D- 15
`glucosamine and D-glucuronic acid monosaccharide
`units linked with ~1-4 bonds and the disaccharide
`units linked with ~1-+3 glycoside bonds. Hyaluronic
`acid usually occurs as the sodium salt. The molecular
`weight of HA is generally within the range of 50,000 up 20
`to 8 X 106 and even higher.
`The prior art describes the cross-linking of HA with
`the use of 1,2,3,4-diepoxybutane in alkaline medium at
`50° C. (T. C. Laurent, K. Hellsing, and B. Gelotte, Acta
`Chem. Scand. 18 [1984), No 1, 274-5). The product 25
`obtained by that method is a gel which substantially
`swells in water.
`It is also known that divinyl sulfone (DVS) is used for
`cross-linking polysaccharides, especially cellulose (U.S.
`Pat. No. 3,357,784).
`BRIEF DESCRIPTION OF THE DRAWINGS
`FIG. 1 is a graphical representation of the experimen(cid:173)
`tal data set forth in Example 3 below; and
`FIG. 2 is a graphical representation of the experimen- 35
`tal data set forth in Example 4 below.
`SUMMARY OF THE INVENTION
`In one aspect thereof, the present invention provides
`highly swollen gels of cross-linked hyaluronic acid.
`In another aspect, the invention provides mixed
`cross-linked gels of hyaluronic acid and other hydro(cid:173)
`phillic polymers.
`In yet another aspect, the invention provides cross(cid:173)
`linked gels of hyaluronic acid and other polymers filled 45
`with various substances.
`In still another aspect, the invention provides cross(cid:173)
`linked gels ofhyaluronic acid containing low molecular
`weight substances covalently attached to the macro(cid:173)
`molecules.
`In still yet another aspect, the invention provides
`various formulations containing cross-linked hyaluronic
`acid gels.
`Finally, the invention provides the methods of pre-
`paring the products of the invention.
`The present invention is based on the observation that
`divinyl sulfone (DVS) reacts readily with HA in aque(cid:173)
`ous alkaline solutions at room temperature, i.e., about
`20° C., thereby providing cross-linked HA gels. As used
`herein, the term HA means hyaluronic acid and its salts 60
`such as the sodium, potassium, magnesium, calcium, etc.
`salts. These gels swell in water and water containing
`media. The swelling ratio depends upon the degree of
`cross-linking of the gel. We have found that the degree
`of cross-linking can be controlled by changing several 65
`factors including the molecular weight of the HA, its
`concentration in the reaction mixture, the alkali concen(cid:173)
`tration and the polymer/DYS ratio. The reaction is
`
`40
`
`55
`
`2
`very fast and in most cases a strong gel can be obtained
`in several minutes. The swelling ratio of these gels can
`be from 20 up to 8000, and more, depending upon the
`reaction parameters.
`It has also been found that the swelling ratio of cross-
`linked HA gels is substantially greater than the swelling
`ratio of cross-linked gels of other polysaccharides ob(cid:173)
`tained under the same reaction conditions. This can
`probably be explained by the unique nature of HA (as
`10 compared to other polysaccharides) and its water solu(cid:173)
`tions. We have found that in water, a large molecule of
`HA forms a very flexible, long random coil which takes
`up an extremely large volume in the solution. For exam-
`ple, the specific volume of a hydrated HA molecule in
`a physiological salt solution is about 2-6X 1Q3 ml/g.
`That means that in a quite low concentration water
`solution of HA, a steric exclusion phenomenon occurs
`which will substantially affect not only the physico-
`chemical properties of the solution, but the reaction of
`the HA with low molecular weight substances as well.
`In other words, the nature of the HA solutions affects
`the degree of cross-linking and the behavior of the
`cross-linked gel, in a manner quite unlike anything that
`occurs with other polysaccharides.
`We have also found that this unique property of HA
`to give highly swollen cross-linked gels can be used to
`effect modification of the properties of cross-linked gels
`made of mixtures of HA with other hydrophillic poly-
`30 mers. These polymers include other polysaccharides,
`synthetic and natural, such as hydroxyethyl cellulose,
`carboxymethyl cellulose, xanthan gum, chondroitin
`sulfate, heparin, proteins of various types, such as colla(cid:173)
`gen, elastin, albumin, a globulin, etc., sulfated proteins
`such as keratin sulfate and sulfated aminoglycosaminog(cid:173)
`lycans, synthetic water-soluble polymers, such as poly(cid:173)
`vinyl alcohol and its co-polymers, co-polymers of poly(cid:173)
`(hydroxyethyl)methacrylate and the like. In other
`words, any polymer soluble in water or water alkaline
`solutions and containing groups capable of reacting
`with DVS, namely, hydroxyl, amino or sulfyhydryl
`groups, can be used to obtain highly swollen cross(cid:173)
`linked mixed gels of HA.
`We have further found that useful products can easily
`be obtained by carrying out the cross-linking reaction of
`HA in the presence of low-molecular weight substances
`containing reactive groups of the mentioned types.
`Another type of material according to the present
`invention is a cross-linked hydrophilic gel filled with
`50 various water insoluble substances including hydrocar(cid:173)
`bons, such as petroleum; an oil or fat such as beeswax,
`conconut oil or lanolin, pigments, such as kaolin, ferric
`oxide; insoluble dyes, polymers, such as polyethylene,
`polyetrafluro ethylene, etc. In this type of product fine
`particles of a filler are immobilized in a gel network or
`in what we call a "polymer cage". This latter product
`can be very useful for several purposes which will be
`discussed in more detail below.
`DESCRIPTION OF THE PREFERRED
`EMBODIMENT
`The processes by which the hereinabove described
`products are obtained will now be discussed in detail.
`In order to obtain a cross-linked HA gel, a sample of
`sodium hyaluronate or hyaluronic acid from any source
`is dissolved in dilute alkaline solution. The molecular
`weight of HA can be from 50,000 up to 8 X 106 and even
`higher. The molecular weight affects the reation-the
`
`

`

`4,605,691
`
`10
`
`25
`
`3
`higher the molecular weight the greater the possibility
`to obtain a cross-linked gel.
`The alkali concentration in the reaction mixture can
`be from 0.005M to 0.5M and higher. The lower limit is
`dictated by the necessity to have the pH of the medium 5
`not lower than 9 and the upper limit by the hydrolysis
`of HA in an alkaline solution. Usually, a decrease in
`alkali concentration results in gels with a greater swell(cid:173)
`ing ratio, probably because a small amount of DVS
`takes part in the cross-linking reaction.
`The concentration of HA in the starting solution can
`vary from 1% by weight up to 8% by weight and
`higher. When the concentration is below the lower
`limit, a cross-linked gel cannot be obtained even at a
`low HA/DVS ratio. When the concentration is too 15
`high, the solution becomes so viscous that it is difficult
`to handle it. The HA concentration substantially affects
`the swelling behavior of the gels (FIG. 1). It was found
`that the shape of the curve for the swelling ratio-the
`HA concentration dependence is essentially the same 20
`for various HA/DVS ratios but the lower this ratio (i.e.,
`more DVS in the mixture), the less the swelling ratio of
`the cross-linked gel for the same concentration of HA in
`the starting mixture.
`We have found that HA/DVS in the reaction mixture
`is another parameter which can be conveniently used to
`control the swelling ratio of the cross-linked HA gel.
`An increase in the ratio results in highly swollen soft
`gels (the swelling ratio is about 4000 and higher) 30
`whereas hard and less swollen gels are obtained when
`this ratio is decreased. In general, the HA/DVS weight
`ratio can be from 15:1 to 1:5 and lower.
`The cross-linking reaction is usually carried out at
`room temperature, i.e., about 20° C., but it can be per- 35
`formed at a lower or higher temperature, if desired.
`However, it should be kept in mind that HA can de(cid:173)
`grade relatively rapidly in alkaline solutions at elevated
`temperatures and, if such degradation occurs, the de(cid:173)
`crease in MW can affect the properties of the obtained 40
`gels.
`The cross-linking reaction is relatively fast and strong
`gels are formed usually in several minutes when the HA
`concentration is high enough and the HA/DVS ratio is
`low. But even at low HA concentration in the reaction 45
`mixture, the gel formation starts usually 5-10 minutes
`after addition of DVS. We have found that in most
`cases one hour is enough for completion of the cross(cid:173)
`linking reaction.
`Another method of controlling the swelling ratio of 50
`cross-linked HA gels involves adding neutral salt to the
`reaction mixture. We have found that the swelling ratio
`of the gels obtained in the presence of water soluble
`neutral salts, such as the chlorides, sulfates, phosphates
`and acetates of alkali metals, decreases with the increase 55
`of salt concentration. A salt can be used in concentra(cid:173)
`tion up to 20 wt. % and higher, depending upon the
`nature of the salt and its effect on the solubility of HA
`in the reaction mixture.
`To obtained cross-linked gels of other hydrophillic 60
`polymers the same reaction conditions as for HA can be
`used. The swelling ratio of these gels can be conve(cid:173)
`niently controlled by incorporating HA into the gel
`structure. When the mixed gels are obtained, the com(cid:173)
`position of the polymer mixture can vary over a broad 65
`range depending on the swelling ratio of the cross(cid:173)
`linked gel desired. The preferred content of HA in the
`mixture is from 5 to 95 wt. %.
`
`4
`Cross-linked gels of HA or other polymers or mixed
`cross-linked gels filled with inert substances are ob(cid:173)
`tained by incorporating these substances into the reac(cid:173)
`tion mixture before the addition of DVS. These inert
`substances are, preferably, water-insoluble liquids or
`solid substances. Examples of such substances are petro(cid:173)
`latum and kaolin. To obtain a filled cross-linked gel, a
`chosen substance (based on a consideration of the de(cid:173)
`sired properties of the gel) is emulsified or dispersed in
`an alkaline solution of HA or other polymer or mixture
`of HA with other polymer or polymers and DVS is
`added to the mixture. The amount of DVS and the
`other parameters of the reaction are selected depending
`upon the desired properties of the gel. The relative
`amount of filler in the gel can vary over a broad range
`and is from 1 to 95 wt. % calculated on the total amount
`of polymers and filler, preferably from 5 to 90 wt. %.
`Cross-linked gels containing low molecular weight
`substances such as drugs, dyes and others covalently
`attached to the macromolecular network are obtained,
`preferably by incorporating the named substances into
`an HA or HA and other polymers solution before the
`addition of DVS. An example of such a substance is
`carminic acid, an FDA approved substance for use in
`food and drug preparations.
`It is probably the presence of a glucosidic moiety of
`· the carminic molecule which takes part in the cross(cid:173)
`linking reaction with DVS. It should be understood that
`a great number of substances can be used to obtain a
`modified cross-linked gel of this type. The only essential
`feature of these substances is that they contain chemical
`groups with active hydrogen atoms reactive to DVS.
`The amount of such low molecular weight substances
`which can be used in the reaction depends upon the
`desired level of that substance in the gel. This amount
`can be in the range of from 1 to 99 wt. % as calculated
`on polymer content in the gel, preferably, 5 to 90 wt. %.
`The cross-linked HA and mixed gels obtained ac(cid:173)
`cording to the present invention can be used for many
`purposes. We have found that these highly swollen gels
`are very useful in cosmetic formulations and can be
`considered as water-retaining and water-delivering in(cid:173)
`gredients in these formulations.
`As HA is known to be a biologically tolerable poly(cid:173)
`mer in the sense that it does not cause any immune or
`other kind of response when introduced into a human
`body, the cross-linked HA gels can be used for various
`medical applications. The cross-linked gels modified
`with other polymers or low molecular weight sub(cid:173)
`stances can be used as drug delivery devices. For exam(cid:173)
`ple, we have found that heparin introduced in a cross(cid:173)
`linked HA gel retains its antithrombogenic activity.
`We have also found that cross-linked gels of HA can
`slow down the release of a low molecular weight sub(cid:173)
`stance dispersed therein but not covalently attached to
`the gel macromolecular matrix.
`The domain of the cross-linked hyaluronic acid
`(alone or co-polymerized with other polyanionic or
`neutral polymers) forms a molecular cage. In this cage,
`hydrophilic or hydrophobic molecules of various phar(cid:173)
`macological or biological activity can be dispersed.
`Thus, the cage constitutes a depot for these substances
`of various molecular size. The substances contained in
`the domain of the molecular cage will be delivered into
`the environment by diffusion. The delivery process is
`controlled by such factors as the exclusion volume ef(cid:173)
`fect and the pore size of the molecular cage and by the
`molecular interaction between the polymeric network
`
`

`

`6
`was obtained which had a swelling ratio in water of
`2910.
`
`EXAMPLE2
`This example illustrates the effect of alkali concentra(cid:173)
`tion on the cross-linking of HA.
`A sample of HA with a MW of about 3 X 1Q6 was
`dissolved in a calculated amount of 0.2M NaOH solu(cid:173)
`tion to give 4% viscous solution to which DVS was
`added in an amount providing an HA/DVS ratio of
`about 5:1. The cross-linking and treatment of the gel
`was carried out as described in the preceding example.
`The swelling ratio of the gel in water was 990.
`The example was repeated but the alkali concentra(cid:173)
`tion was 0.0IM. A gel was obtained with a swelling
`ratio in water of 3640. Thus, a decrease in the alkali
`concentration in the reaction mixture results in a gel
`with substantially greater swelling in water.
`EXAMPLE3
`This example illustrates the effect of varying the HA
`concentration in the starting mixture on the swelling
`behavior of the resulting gel.
`Eight solutions of sodium hyaluronate in 0.2M so(cid:173)
`dium hydroxide solution were prepared with the HA
`concentration being 2.0, 2.5, 3.0, 3.5, 4.0, 5.5, 8.0 and
`10.0% by weight respectively. To each solution a calcu(cid:173)
`lated amount ofDVS was added to have a weight ratio
`of HA/DVS about 1 (molar ratio about 0.33). The
`cross-linked gels were obtained as described in the
`above examples and treated accordingly. The swelling
`ratio was determined for each sample and plotted
`against starting HA concentration. The results are
`shown in FIG. 1.
`
`20
`
`4,605,691
`5
`and the substance contained therein. Thus, the molecu(cid:173)
`lar cage forms a depot for the controlled delivery of
`drugs or other substances to the skin or other tissues.
`There is one additional property of the cross-linked
`HA gels which makes them potentially very useful as 5
`drug delivery devices. The swelling ratio of these gels
`in water depends substantially upon the salt concentra(cid:173)
`tion in the medium and decreases several times with an
`increase in salt concentration. This means that a gel
`swollen in water will contract substantially when intro- IO
`duced into the body (because of the normal salt content
`of the body fluids and tissues), thus delivering its con(cid:173)
`tents, i.e., an incorporated drug, into the body tissue.
`The cross linked gels filled with various substances
`can also be used in cosmetic formulations. For example, 15
`a gel with petrolatum incorporated therein gives all the
`benefits of using petrolatum in cosmetic formulations
`without the unpleasant greasy feeling which is normally
`observed with petrolatum containing formulations.
`DETAILED DESCRIPTION OF THE
`INVENTION
`The present invention is described in more detail in
`the following examples, wherein all parts given are by
`weight unless otherwise indicated. These examples are 25
`given merely by way of illustration and are not intended
`to limit the invention as set forth in the claims.
`EXAMPLE 1
`This example illustrates the effect of varying HA 30
`molecular weight on the cross-linking reaction.
`0.3410 g. of sodium hyaluronate obtained from
`rooster combs (intrinsic viscosity in 0.1 SM solution of
`NaCl [71] 3850, MW about 2.5 X 106) was mixed with
`8.1840 g. of 0.2M NaOH solution to give a 4% by 35
`weight solution after stirring for 30 minutes. Then,
`0.0721 g. of DVS was stirred into the solution. The
`weight ratio HA/DVS was about 4.7. A strong gel
`formed in about 15 minutes. The gel was left for one
`hour and then put into one liter of distilled water. The 40
`gel was left to swell in water overnight. Then it was
`broken into small particles by vigorous stirring in water.
`The gel particles were filtered off and washed several
`times with water. Colorless, water clear particles were
`obtained. To determine the swelling ratio of the gel, a 45
`sample weighing about 1 g. was centrifuged in a glass
`filter at 3,000 rpm for two hours. Then the particles left
`on the filter were hydrolyzed with 2 ml of IN H2SO4
`solution for three hours at 95°-98° C. The clear solution
`obtained was neutralized upon cooling with 2 ml of IN 50
`NaOH solution and the glucuronic acid content was
`determined by the carbazole method (An Automated
`Method For The Determination Of Hexuronic Acids,
`Analytical Biochemistry, 2, 517-558 [1965]). The HA
`content in the starting gel was calculated and the swell- 55
`ing ratio was expressed as 100/[HA]%, where [HA]%
`is a percent of HA in the swollen gel.
`The swelling ratio in water of the gel obtained was
`820.
`This example was repeated with the exception that 60
`the solution of HA in alkali was kept at room tempera(cid:173)
`ture for 24 hours. This led to a HA hydrolysis. The
`intrinsic viscosity [71) of the polymer was 1064 which
`corresponded to a MW of about 0.5 X 1Q6. A cross(cid:173)
`linked gel could not be obtained from this polymer at 65
`the HA/DVS ratio used above.
`The example with the degraded HA was repeated but
`the HA/DVS ratio used was about 2. A cross-linked gel
`
`EXAMPLE4
`This example illustrates the effect of varying the
`HA/DVS ratio on the swelling behavior of the result-
`ing gel.
`.
`Six solutions of sodium hyaliironate in 0.2M sodium
`hydroxide solution were prepared with a concentration
`of 4.0% by weight. To each solution a calculated
`amount of DVS was added to have the following
`HA/DVS ratios: 0.2, 0.3, 0.5, 1.0, 1.5 and 2.0 mole/(cid:173)
`mole. The cross-linked gels were obtained and treated
`as described in the preceding examples. The swelling
`ratio was determined for each sample and plotted
`against HA/DVS ratio in the reaction mixture. The
`results are shown in FIG. 2.
`EXAMPLES
`This example illustrates the effect of sodium chloride
`in the reaction mixture on the swelling ratio of the
`cross-linked gel.
`Two samples of the cross-linked HA gel were pre(cid:173)
`pared with the use of the above described procedure.
`Sodium hyaluronate concentration in 0.2M sodium hy(cid:173)
`droxide was 4% by weight. The HA/DVS ratio was
`about 5:1, the reaction time one hour. To the second
`reaction mixture sodium chloride was added in an
`amount to have a 1.0 molar salt concentration. The
`swelling ratio of the first gel was 2380, whereas the gel
`obtained in the presence of salt had a swelling ratio in
`water of 650.
`
`EXAMPLE6
`This example illustrates the cross-linking of hyrox(cid:173)
`yethyl cellulose with the use of DVS.
`
`

`

`7
`0.4312 g. of air-dry hydroxyethyl cellulose (Cellosize
`OP-100000@, Union Carbide) was dissolved with stir(cid:173)
`ring in 10.3 g. of 0.2N sodium hydroxide to give 4% by
`weight. 0.0855 g. of DYS was stirred into this solution
`(polymer/DYS ratio was about 5:1 by weight) and the 5
`mixture was left for one hour at room temperature. A
`cross-linked gel was obtained which was processed as
`described in Example l. To determine the polymer
`concentration in the gel and, hence, the swelling ratio, a
`weighed sample of the gel was put into acetone, kept 10
`overnight, washed several times with acetone and dried
`in a vacuum oven at 50° C. to a constant weight. The
`swelling ratio of the gel obtained was 43 which is sub(cid:173)
`stantially less than for cross-linked HA gel obtained
`under the same reaction conditions.
`
`I 5
`
`4,605,691
`
`8
`In each example, sodium hyaluronate and carboxy(cid:173)
`methyl cellulose 9H4F were dissolved in 0.2M sodium
`hydroxide solution in such amounts as to provide spe(cid:173)
`cific ratios of the two polymers In all cases the total
`polymer concentration was 4% by weight and the poly(cid:173)
`mer/DYS ratio was about 5:1. The gels were obtained
`and processed as described above. The polymer content
`in the gels was determined as described in Example 1,
`with the exception that the hexosamine concentration
`(instead of glucoronic acid) was determined by a known
`method (A Rapid Procedure for the Estimation of
`Amino Sugars on a Micro Scale, Analytical Biochemis(cid:173)
`try 15, 167-171 [1966]) in the hydrolyzate. The polymer
`content was calculated from the HA concentration and
`the ratio of the two polymers.
`
`EXAMPLE7
`This example illustrates the cross-linking of xanthan
`gum with the use of DYS.
`0.4935 g. of air-dry xanthan gum (Kelzan@, Kelco) 20
`was dissolved in 11.3 g. of 0.2M sodium hydroxide
`solution to give a 4% by weight solution. To this solu(cid:173)
`tion 0.0718 g. of DYS was added (the polymer/DYS
`ratio was about 7:1 by weight). The mixture was kept
`for an hour at room temperature. The cross-linked gel
`finally obtained was put into a large volume of water,
`left to swell overnight and broken into small pieces
`which were extensively washed with water.
`The. swelling ratio of the gel determined by the 30
`weight method described in the preceding example was
`526, which is substantially less than for cross-linked HA
`gel obtained under the same reaction conditions.
`
`25
`
`35
`
`EXAMPLES
`This example illustrates the cross-linking of a cationic
`water-soluble cellulose polymer with the use DYS.
`0.5483 g. of a cationic cellulose polymer obtained by
`chemical modification of hydroxyethyl cellulose (Poly(cid:173)
`mer Deare JR@, Union Carbide) was dissolved in 40
`13.71 g. of 0.2M sodium hydroxide solution to give a
`4% by weight solution to which 0.0849 g. of DYS was
`added (the polymer/DYS ratio was about 6.5:1). The
`reaction mixture was left to stand for an hour at room
`temperature and the gel obtained was processed and 45
`analyzed as described in the preceding example. The
`swelling ratio of the gel in water was 386, which is
`substantially less than that for a cross-linked HA gel
`obtained under the same reaction conditions.
`
`50
`
`EXAMPLE9
`This example illustrates the cross-linking of carboxy(cid:173)
`methyl cellulose with the use of DYS.
`0.4703 g. of carboxymethyl cellulose sodium salt (9H
`4F, Hercules) was dissolved in 11. 76 g. of 0.2M NaOH 55
`to give a 4% by weight solution to which 0.0651 g. of
`DYS was added (the polymer/DYS ratio was about
`7:1). The reaction mixture was kept for an hour at room
`temperature and the gel obtained was processed and
`analysed as described in. the preceding example. The 60
`swelling ratio in water was 893, which is more than that
`obtained for other cellulosic polymers but less than for
`cross-linked HA gel.
`
`EXAMPLES 1~13
`These examples illustrate mixed cross-linked gels
`made of HA and carboxymethyl cellulose and the effect
`of the HA content on the swelling ratio of the gels.
`.
`
`65
`
`HA Content in the Starting
`Mixture, Wt. %
`
`Swelling Ratio
`in Water
`
`Example 10
`Example II
`Example 12
`Example 13
`
`70
`50
`20
`0
`
`8196
`6757
`1117
`623
`
`As can be seen from these data, an increase in the HA
`content in the starting mixture results in an increase in
`the swelling ratio of the resulting gels.
`
`EXAMPLE 14
`This example illustrates mixed cross-linked gels ob(cid:173)
`tained from HA and collagen. 0.2531 g. of dry sodium
`hyaluronate was dissolved in 2.5 ml of O. lM sodium
`hydroxide solution. 0.063 g. of collagen obtained from
`human umbilical cord was dissolved in 2.3 ml of O. IM
`acetic acid and the two solutions were combined. The
`total polymer concentration was 6 wt. % and the
`weight ratio HA/collagen was about 4:1. 0.05 g. of dry
`KC! was dissolved in the mixed solution and DVS was
`stirred into the reaction mixture in an amount providing
`a polymer/DYS ratio of about 5:1. The reaction mix(cid:173)
`ture was kept at room temperature for an hour and the
`gel obtained was treated as described above. The poly(cid:173)
`mer content in the swollen gel was calculated from the
`HA content which was found by the glucuronic acid
`assay. A strong and resilient gel was obtained which
`had a swelling ratio in water of 321.
`EXAMPLE 15
`This example illustrates a mixed cross-linked HA-col(cid:173)
`lagen gel with a higher content of collagen and a lower
`swelling ratio than the gel described in Example 14.
`0.2544 g. of sodium hyaluronate was dissolved in 3.5
`ml of 0.2M sodium hydroxide solution. 0.1192 g. of
`collagen obtained from human umbilical crod was dis(cid:173)
`solved in 1.5 ml of 0.2M acetic acid solution and the
`solutions were combined. The total polymer concentra(cid:173)
`tion was 7.5 wt. % and the weight ratio HA/collagen
`was about 2: 1. 0.05 g. of sodium chlori4e was dissolved
`in the mixed solution to which 0.1189 g. of DYS was
`added, thus providing a polymer/DYS ratio of about
`3:1 by weight. The gel was obtained and processed as
`described in the preceding example. A strong gel was
`obtained with a swelling ratio of 35.
`
`EXAMPLE 16
`This example illustrates a mixed cross-linked gel of
`HA and heparin.
`
`

`

`10
`hydroxide solution to give an approximately 4 wt. %
`solution of polymer. 0.40 g. of DYS was added to the
`solution (polymer/DYS ratio was 1:2) and the mixture
`was left for an hour at room temperature. The gel ob-
`5 tained was processed as described in the preceding
`examples
`Red colored transparent gel particles were obtained
`and the color did not disappear after extensive washing
`with water. The swelling ratio in water determined by
`10 the weight method was 115.
`EXAMPLE21
`This example illustrates the effect of salt concentra(cid:173)
`tion in water on the swelling behavior of a cross-linked
`HA gel.
`A cross-linked HA gel was obtained as described in
`the preceding examples such an HA concentration in
`0.2M NaOH of 4 wt. %; HA/DYS ratio 5:1, at room
`temperature for one hour. The gel particles were put
`into water and aqueous sodium chloride solution of
`different concentrations and the swelling ratios were
`determined. The following results were obtained:
`
`NaCl Concentration, M
`Swelling Ratio
`Water
`990
`0.05
`413
`0.15
`384
`0.50
`219
`1.00
`176
`30 - - - - - - - - - - - - - - - - - - - - -
`
`4,605,691
`9
`0.2968 g. of dry sodium hyaluronate was dissolved in
`6.92 g. of 0.2M sodium hydroxide solution to give a 4
`wt. % solution to which 0.0503 g. of heparin was added.
`The heparin content calculated on the basis of the total
`amount of polymers was 14.5 wt. %. 0.0590 g. of DYS
`was stirred into the mixture. The reaction was carried
`out for an hour at room temperature. The obtained gel
`was processed as described in the preceding examples.
`The swelling ratio of the gel was 625.
`EXAMPLE 17
`This example illustrates a cross-linked hydroxyethyl
`cellulose gel filled with petrolatum.
`0.5292 g. of dry hydroxyethyl cellulose was dissolved
`in 10.58 g. of IM sodium hydroxide solution and 1.058 15
`g. of white petrolatum was stirred into the solution. The
`petrolatum/polymer ratio was about 2. A solution of
`0.1771 g. of DYS in 1.0 g. of IM sodium hydroxide
`solution was added to the emulsion with vigorous stir(cid:173)
`ring. The reaction mixture was left for an hour at room 20
`temperature and the gel obtained was treated as de(cid:173)
`scribed in the above examples. To find the petrolatum
`content in the gel, a gel sample was digested with 2 ml
`of IN H2SO4 at 95° C. for three hours. Then 2 ml of IN
`NaOH was added to the mixture followed by 4 ml of 25
`xylene to extract the petrolatum. The extract was dried
`off in vacuum and the residue was weighed. The calcu(cid:173)
`lated petrolatum content in the gel was 6 wt. %.
`EXAMPLE 18
`This example illustrates a mixed HA-carboxymethyl
`cellulose gel filled with petrolatum.
`0.1830 g. of dry sodium hyaluronate and the same
`amount of carboxymethyl cellulose were dissolved in
`9.1 g. of0.2N sodium hydroxide solution to give a 4 wt. 35
`% solution of polymer. 0.3660 g. of petrolatum was
`stirred into the solution and 0.0730 of DYS was added
`to the resulting emulsion with vigorous stirring. The
`polymer/DYS ratio was about 5:1. The reaction mix(cid:173)
`ture was left for an hour at room temperature. The 40
`obtained gel was processed as described in the preced(cid:173)
`ing example. The swelling ratio of the gel determined
`through hexosamine content was 738 and the petrola(cid:173)
`tum content determined as in the preceding example
`was 0.1 wt. %.
`
`45
`
`EXAMPLE22
`This example illustrates the biological activity of a
`mixed HA-heparin cross-linked gel.
`Fine particles of the mixed HA-heparin cross-linked
`gel prepared according to Exam

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket